北美心脏辅助设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按产品(主动脉内球囊泵、全人工心脏、心室辅助装置)和地理划分。

市场快照

North America Cardiac Assist Devices Market Overview
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 8.1 %
North America Cardiac Assist Devices Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

辅助设备技术的持续快速进步和现有治疗的新应用导致对心脏辅助设备的需求增加。导致市场增长的其他因素是缺乏供移植的心脏、人口老龄化和心脏病增加。这些因素导致在患有严重心脏并发症的患者中植入心脏辅助装置的使用增加。根据美国心脏协会关于心脏病和中风的报告,2017 年约有 80 万人死于心血管疾病。然而,替代疗法(如起搏器)的可用性以及与设备植入相关的风险可能会阻碍心脏辅助设备的市场。

报告范围

根据报告的范围,辅助装置被定义为与心脏一起工作的机械泵类型,以提高泵送效率并保持整个身体的最佳血液流动。心脏辅助装置用于治疗终末期心力衰竭,并由个人的需要决定。它们分为三种类型,即心室辅助装置、主动脉内球囊泵(IABP)和全人工心脏。

By Product
Intra-aortic Balloon Pumps
Total Artificial Heart
Ventricular Assist Devices
Left Ventricular Assist Device
Right Ventricular Assist Device
Geography
North America
United States
Canada
Mexico

Report scope can be customized per your requirements. Click here.

主要市场趋势

总人工心脏部门主导北美心脏辅助设备市场

心脏移植是终末期心力衰竭最有效的治疗方法。不幸的是,供体心脏的供应并不能满足日益增长的需求。许多患者在被列入等候名单时死亡。尽管对供体心脏的需求有所增加,但供体器官的数量却减少了。这导致市场对人工心脏的需求呈指数增长。对于患有晚期心力衰竭问题的患者,全人工心脏被认为是最佳的长期解决方案之一。各种体外和心室辅助装置只能被视为临时解决方案。一些提供心脏辅助设备的公司是 Abbott Laboratories 和 Syncardia。

North America Cardiac Assist Devices Market Key Trends

North America Cardiac Assist Devices Market Growth Rate

竞争格局

北美心脏辅助设备市场本质上是高度分散的,有许多知名参与者。参与者正专注于重大合作、合并和收购,以提高他们的市场份额。市场参与者还专注于研发,以提高产品质量并最大限度地降低制造成本。此外,他们正在开发更安全的设备,以提高患者的依从性和安全性。一些顶级市场参与者包括 Abiomed Inc.、Abbott Laboratories、Medtronic、Syncardia 和 Berlin Heart Gmbh 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Heart Diseases

      2. 4.2.2 Advancements in Technology

      3. 4.2.3 Shortage of Heart Donors in Transplantation

    3. 4.3 Market Restraints

      1. 4.3.1 Risk Associated with Device Implantation

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Intra-aortic Balloon Pumps

      2. 5.1.2 Total Artificial Heart

      3. 5.1.3 Ventricular Assist Devices

        1. 5.1.3.1 Left Ventricular Assist Device

        2. 5.1.3.2 Right Ventricular Assist Device

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abiomed Inc.

      2. 6.1.2 Abbott Laboratories

      3. 6.1.3 Bioheart Inc.

      4. 6.1.4 Cardiac Assist Inc.

      5. 6.1.5 Calon Cardio-Technology Ltd

      6. 6.1.6 LivaNova PLC (Cardiac Assist Inc.)

      7. 6.1.7 Cardiokinetix Inc.

      8. 6.1.8 Medtronic Plc

      9. 6.1.9 SynCardia Systems LLC

      10. 6.1.10 ReliantHeart

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Cardiac Assist Devices Market market is studied from 2018 - 2026.

The North America Cardiac Assist Devices Market is growing at a CAGR of 8.1% over the next 5 years.

Abiomed Inc., Abbott Laboratories, Medtronic, (LivaNova PLC) CardiacAssist Inc., SynCardia Systems LLC are the major companies operating in North America Cardiac Assist Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!